D.Western Therapeutics Institute,Inc.is a biotechnology company that focuses on development of innovative new drags to serve patients worldwide.

Business Model

Development of Drug Creation Business through Licensing Out

The Company concentrates management resources in drug creation which is said to be in the upstream of pharmaceutical business and produces innovative drug candidate compounds. We aim at licensing out the created drug candidate compounds at an early stage. The Company gains revenue by promoting these business models.

The Company’s Business Models Diagram

pdficon_large316KB(Enlarge the above diagram)

Our major sales from these business models consist of:

  1. Front money income to be received at the time of licensing out;
  2. Milestone income to be received at each milestone as the clinical studies progress; and
  3. Royalty income to be received at a fixed ratio of the post-launch sales turnover.
D.Western Therapeutics Institute, Inc.
1-18-11, Nishiki, Naka-ku,
Nagoyashi, Aichi 460-0003 Japan
TEL 81+52-218-8785
Copyright © D.Western Therapeutics Institute, Inc. All Rights Reserved.